Goitre

Signs and symptoms

A goitre can present as a palpable or visible enlargement of the thyroid gland at the base of the neck. A goitre, if associated with hypothyroidism or hyperthyroidism, may be present with symptoms of the underlying disorder. For hyperthyroidism, the most common symptoms are associated with adrenergic stimulation: tachycardia (increased heart rate), palpitations, nervousness, tremor, increased blood pressure and heat intolerance. Clinical manifestations are often related to hypermetabolism (increased metabolism), excessive thyroid hormone, an increase in oxygen consumption, metabolic changes in protein metabolism, immunologic stimulation of diffuse goitre, and ocular changes (exophthalmos). Hypothyroid people commonly have poor appetite, cold intolerance, constipation, lethargy and may undergo weight gain. However, these symptoms are often non-specific and make diagnosis difficult.

According to the WHO classification of goitre by palpation, the severity of goitre is currently graded as grade 0, grade 1, grade 2.

File:Struma 001.jpg|Goitre Class II, WHO grade 2 File:Kone med stor struma.jpg|Goitre Class III, WHO grade 2

Causes

Worldwide, the most common cause for goitre is iodine deficiency, commonly seen in countries that scarcely use iodised salt. Selenium deficiency is also considered a contributing factor. In countries that use iodised salt, Hashimoto's thyroiditis is the most common cause. Goitre can also result from cyanide poisoning, which is particularly common in tropical countries where people eat the cyanide-rich cassava root as the staple food.

• Sarcoidosis
• Amyloidosis
• Hydatidiform mole
• Cysts
• Acromegaly
• Pendred syndrome

Diagnosis

Goitre may be diagnosed via a thyroid function test.

Types

A goitre may be classified either as nodular or diffuse. Nodular goitres are either of one nodule (uninodular) or of multiple nodules (multinodular). Multinodular goitre is the most common disorder of the thyroid gland.

;Growth pattern:

• Uninodular goitre: one thyroid nodule; can be either inactive, or active (toxic) – autonomously producing thyroid hormone.
• Multinodular goitre: multiple nodules; can likewise be inactive or toxic, the latter is called toxic multinodular goitre and associated with hyperthyroidism. These nodules grow up at varying rates and secrete thyroid hormone autonomously, thereby suppressing TSH-dependent growth and function in the rest of gland. Inactive nodules in the same goitre can be malignant. Thyroid cancer is identified in 13.7% of the patients operated for multinodular goitre.
• Diffuse goitre: the whole thyroid appearing to be enlarged due to hyperplasia.

;Size:

• Class I: the goitre in normal posture of the head cannot be seen; it is only found by palpation.
• Class II: the goitre is palpable and can be easily seen.
• Class III: the goitre is very large and is retrosternal (partially or totally lying below the sternum), pressure results in compression marks.

Treatment

Goitre is treated according to the cause. If the thyroid gland is producing an excess of thyroid hormones (T3 and T4), radioactive iodine is given to the patient to shrink the gland. If goitre is caused by iodine deficiency, small doses of iodide in the form of Lugol's iodine or KI solution are given. If the goitre is associated with an underactive thyroid, thyroid supplements are used as treatment. Sometimes a partial or complete thyroidectomy is required.

Medical and scientific developments

The discovery of iodine's importance in thyroid function and its role in preventing goitre marked a significant medical breakthrough. The introduction of iodised salt in the early 20th century became a key public health initiative, effectively reducing the prevalence of goitre in previously affected regions. This measure was one of the earliest and most successful examples of mass preventive health campaigns.

Epidemiology

]] Goitre is more common among women, but this includes the many types of goitre caused by autoimmune problems, and not only those caused by simple lack of iodine.

Iodine mainly accumulates in the sea and in the topsoil. Before iodine enrichment programs, goiters were common in areas with repeated flooding or glacial activities, which erodes the topsoil. It is endemic in populations where the intake of iodine is less than 10 μg per day.

Examples of such regions include the alpine regions of Southern Europe (such as Switzerland), the Himalayans, the Great Lakes basin, etc. As reported in 1923, all the domestic animals have goiter in some of the glacial valleys of Southern Alaska. It was so severe in Pemberton Meadows that it was difficult to raise young animals there.

History

Chinese physicians of the Tang dynasty (618–907) were the first to successfully treat patients with goitre by using the iodine-rich thyroid gland of animals such as sheep and pigs—in raw, pill, or powdered form. This was outlined in Zhen Quan's (d. 643 AD) book, as well as several others. One Chinese book, The Pharmacopoeia of the Heavenly Husbandman, asserted that iodine-rich sargassum was used to treat goitre patients by the 1st century BC, but this book was written much later.

In the 12th century, Zayn al-Din al-Jurjani, a Persian physician, provided the first description of Graves' disease after noting the association of goitre and a displacement of the eye known as exophthalmos in his Thesaurus of the Shah of Khwarazm, the major medical dictionary of its time. The disease was later named after Irish doctor Robert James Graves, who described a case of goitre with exophthalmos in 1835. The German Karl Adolph von Basedow also independently reported the same constellation of symptoms in 1840, while earlier reports of the disease were also published by the Italians Giuseppe Flajani and Antonio Giuseppe Testa, in 1802 and 1810 respectively, and by the English physician Caleb Hillier Parry (a friend of Edward Jenner) in the late 18th century.

Paracelsus (1493–1541) was the first person to propose a relationship between goitre and minerals (particularly lead) in drinking water. Iodine was later discovered by Bernard Courtois in 1811 from seaweed ash.

Goitre was previously common in many areas that were deficient in iodine in the soil. For example, in the English Midlands, the condition was known as Derbyshire Neck. In the United States, goitre was found in the Appalachian, Great Lakes, Midwest, and Intermountain regions. The condition is now practically absent in affluent nations, where table salt is supplemented with iodine. However, it is still prevalent in India, China, Central Asia, and Central Africa.

Goitre had been prevalent in the alpine countries for a long time. Switzerland reduced the condition by introducing iodised salt in 1922. The Bavarian tracht in the Miesbach and Salzburg regions, which appeared in the 19th century, includes a choker, dubbed Kropfband (struma band) which was used to hide either the goitre or the remnants of goitre surgery.

In various regions around the world, particularly in mountainous areas, the prevalence of goitre was linked to iodine deficiency in the diet. For example, the Alps, the Himalayas, and the Andes had high rates of goitre due to the iodine-poor soil. In these regions, iodine deficiency led to widespread hormonal imbalances, particularly affecting thyroid function.

Society and culture

In the 1920s wearing bottles of iodine around the neck was believed to prevent goitre.

Notable cases

• Former U.S. President George H. W. Bush and his wife Barbara Bush were both diagnosed with Graves' disease and goitres, within two years of each other. The disease caused hyperthyroidism and cardiac dysrhythmia. Scientists said that, absent an environmental cause, the odds of both a husband and wife having Graves' disease might be 1 in 100,000 or as low as 1 in 3,000,000.

Heraldry

The coat of arms and crest of Die Kröpfner, of Tyrol, showed a man "afflicted with a large goitre", an apparent pun on the German for the word ("Kropf").

Social Impacts

In some historical contexts, goitres were so prevalent that they became normalized within the culture. For instance, in certain Alpine regions, large goitres were sometimes considered a sign of beauty. Conversely, in other areas, individuals with goitres faced social stigma, which could lead to marginalisation and discrimination.

References

References

1. (11 September 2019). "Thyroid Nodules and Swellings". British Thyroid Foundation.
2. (2017-10-19). "Goitre - NHS Choices". NHS Choices.
3. (2005). "Schilddrüsenkrankheiten Leitfaden für Praxis und Klinik".
4. (2011). "Essentials of Pathophysiology: Concepts of Altered Health States". Lippincott Williams & Wilkins.
5. (2014). "Goitre as a determinant of the prevalence and severity of iodine deficiency disorders in populations". World Health Organization.
6. (2007). "Robbins Basic Pathology". Saunders.
7. "Toxicological Profile For Cyanide".
8. (November 2010). "Hashimoto thyroiditis and thyroid gland anomalies". The Journal of Craniofacial Surgery.
9. [http://www.uptodate.com/contents/thyrotropin-tsh-secreting-pituitary-adenomas Thyrotropin (TSH)-secreting pituitary adenomas.] By Roy E Weiss and Samuel Refetoff. Last literature review version 19.1: January 2011. This topic last updated: 2 July 2009
10. (November 2005). "Graves' disease: a long-term quality-of-life follow up of patients randomized to treatment with antithyroid drugs, radioiodine, or surgery". Thyroid.
11. (2005). "Thyroid cancer". Springer.
12. (August 2014). "Improvement of quality of life in patients with benign goiter after surgical treatment". Langenbeck's Archives of Surgery.
13. (19 October 2017). "Goitre".
14. (2021). "Gnepp's Diagnostic Surgical Pathology of the Head and Neck".
15. (2000). "Endotext". MDText.com, Inc..
16. (2004). "Benign multinodular goiter". Scandinavian Journal of Surgery.
17. "Toxic multinodular goitre - Symptoms, diagnosis and treatment {{!}} BMJ Best Practice".
18. (August 2004). "The incidence of thyroid carcinoma in multinodular goiter: retrospective analysis". Acta Bio-Medica.
19. "Goiter – Simple". The New York Times.
20. Hetzel, Basil S.. (1993). "The Iodine Deficiency Disorders". Springer US.
21. (2002). "Mortality and Burden of Disease Estimates for WHO Member States in 2002". World Health Organization.
22. 1
23. [https://web.archive.org/web/20210606021115/https://apps.who.int/iris/bitstream/handle/10665/133706/WHO_NMH_NHD_EPG_14.5_eng.pdf Goitre as a determinant of the prevalence and severity of iodine deficiency disorders in populations], World Health Organization - 2014
24. Kimball, O. P.. (February 1923). "The Prevention of Simple Goiter". American Journal of Public Health.
25. (1986). "The Genius of China: 3,000 Years of Science, Discovery, and Invention". Simon and Schuster, Inc..
26. {{WhoNamedIt. synd. 1517. Basedow's syndrome or disease – the history and naming of the disease
27. (August 1983). "[Who was the man behind the syndrome: Ismail al-Jurjani, Testa, Flagani, Parry, Graves or Basedow? Use the term hyperthyreosis instead]". Läkartidningen.
28. {{WhoNamedIt. doctor. 1471. Giuseppe Flajani
29. (June 1998). "Caleb Hillier Parry 1755-1822: a notable provincial physician". Journal of the Royal Society of Medicine.
30. [https://www.britannica.com/EBchecked/topic/442424/Paracelsus/5505/Assessment "Paracelsus"] Britannica
31. (31 December 1814). "VI. Some experiments and observations on a new substance which becomes a violet coloured gas by heat". Philosophical Transactions of the Royal Society of London.
32. "Iodine Deficiency".
33. (1977). "Kentucky Appalachian Goiter Without Iodine Deficiency". American Journal of Diseases of Children.
34. [https://www.nytimes.com/2006/12/16/health/16iodine.html "In Raising the World's I.Q., the Secret's in the Salt"], article by Donald G. McNeil, Jr., 16 December 2006, ''[[The New York Times]]''
35. Wissen, Planet. (16 March 2017). "Planet Wissen".
36. (June 2001). "Damaged Reproduction: The Most Important Consequence of Iodine Deficiency". The Journal of Clinical Endocrinology & Metabolism.
37. (2011-09-30). "ARCHIVED – Why take iodine?". Nrc-cnrc.gc.ca.
38. (2004-07-20). "Women and Autoimmune Disease". HarperCollins.
39. (14 September 1991). "A White House Puzzle: Immunity Ailments". The New York Times.
40. (28 May 1991). "The Doctor's World; A White House Puzzle: Immunity Ailments". The New York Times.
41. (1904). "The Art of Heraldry: An Encyclopædia of Armory". Benjamin Blom, Inc..
42. Norling, Bernard. (October 1977). "Plagues and Peoples - William H. McNeill: Plagues and Peoples. (Garden City, New York: Anchor Press, Doubleday, 1976. Pp. 369. $10.00.)". The Review of Politics.